Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Nr. CRSII3_136179)
Deutsche Forschungsgemeinschaft (EXC 294)
Bundesministerium für Bildung und Forschung (03Z22CN11)
Article History
Received: 10 July 2018
Revised: 3 December 2018
Accepted: 9 December 2018
First Online: 10 January 2019
Ethics approval and consent to participate
: Human marrow-derived mesenchymal stem cells (MSCs) were obtained from patients under informed consent in accordance with the regulations of the institution’s ethical committee (University Hospital Basel; ref. number of the local ethical committee: 78/07).
: Not applicable
: Oliver Otto is a co-founder of a company developing and distributing real-time deformability cytometry.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.